Skip to main content
Clinical Trials/NCT03982784
NCT03982784
Completed
Not Applicable

Transmuscular Quadratus Lumborum Block for Postoperative Pain After Laparoscopic Partial Nephrectomy: A Randomized Controlled Trial

Cui Xulei1 site in 1 country60 target enrollmentJune 10, 2019

Overview

Phase
Not Applicable
Intervention
single-injection TQLB(transmuscular quadratus lumborum block)
Conditions
Laparoscopic Renal Surgery
Sponsor
Cui Xulei
Enrollment
60
Locations
1
Primary Endpoint
cumulative morphine consumption 8 hours after surgery
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay,et al. between single-injection QLB(quadratus lumborum block)+ intravenous patient-controlled analgesia (IPCA) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing laparoscopic partial nephrectomy.

Registry
clinicaltrials.gov
Start Date
June 10, 2019
End Date
November 10, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Cui Xulei
Responsible Party
Sponsor Investigator
Principal Investigator

Cui Xulei

attending physician

Peking Union Medical College Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • A known allergy to the drugs being used
  • Coagulopathy, on anticoagulants
  • Analgesics intake, history of substance abuse
  • Participating in the investigation of another experimental agent
  • Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

Arms & Interventions

single-injection TQLB(transmuscular quadratus lumborum block)

Single-injection of TQLB is given preoperatively + postoperative IPCA(intravenous patient controlled analgesia)

Intervention: single-injection TQLB(transmuscular quadratus lumborum block)

single-injection TQLB(transmuscular quadratus lumborum block)

Single-injection of TQLB is given preoperatively + postoperative IPCA(intravenous patient controlled analgesia)

Intervention: Morphine given as IPCA(intravenous patient controlled analgesia)

Control

postoperative IPCA is given alone

Intervention: Morphine given as IPCA(intravenous patient controlled analgesia)

Outcomes

Primary Outcomes

cumulative morphine consumption 8 hours after surgery

Time Frame: at the 8 hours after surgery

Secondary Outcomes

  • cumulative morphine consumption at other time points after surgery(at 0, 2, 4, 12, 24 and 48 hours after surgery)
  • episodes of nausea and vomiting(within 24 hours after the surgery)
  • quality of recovery evaluated by the self-assessment 15-item quality of recovery (QoR) scale(at 72 hours and 120 hours after the sugery)
  • ambulation time(within the 5 days after surgery)
  • The pain scores(at rest or on activity) determined by the numeric rating scale (NRS, 0-10)(at 0, 2, 4, 8,12, 24, 48 and 72 hours after surgery)
  • time of recovery of bowl movement(within the 5 days after surgery)
  • patient satisfaction with anesthesia(at 48 hours after surgery)
  • postoperative length of hospital stay(within 2 weeks after the surgery)

Study Sites (1)

Loading locations...

Similar Trials